mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia

Epilepsia
Lena H NguyenAnne E Anderson

Abstract

Hyperactivation of the mechanistic target of rapamycin (mTOR; also known as mammalian target of rapamycin) pathway has been demonstrated in human cortical dysplasia (CD) as well as in animal models of epilepsy. Although inhibition of mTOR signaling early in epileptogenesis suppressed epileptiform activity in the neuron subset-specific Pten knockout (NS-Pten KO) mouse model of CD, the effects of mTOR inhibition after epilepsy is fully established were not previously examined in this model. Here, we investigated whether mTOR inhibition suppresses epileptiform activity and other neuropathological correlates in adult NS-Pten KO mice with severe and well-established epilepsy. The progression of epileptiform activity, mTOR pathway dysregulation, and associated neuropathology with age in NS-Pten KO mice were evaluated using video-electroencephalography (EEG) recordings, Western blotting, and immunohistochemistry. A cohort of NS-Pten KO mice was treated with the mTOR inhibitor rapamycin (10 mg/kg i.p., 5 days/week) starting at postnatal week 9 and video-EEG monitored for epileptiform activity. Western blotting and immunohistochemistry were performed to evaluate the effects of rapamycin on the associated pathology. Epileptiform activity...Continue Reading

References

Nov 30, 2000·Current Treatment Options in Neurology·P B Crino, K Chou
Sep 30, 2004·Annals of Neurology·Hajime MiyataHarry V Vinters
Sep 30, 2004·Annals of Neurology·Marianna BaybisPeter B Crino
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Aug 17, 2006·Annals of Neurology·M Cecilia LjungbergGabriella D'Arcangelo
Apr 20, 2007·Experimental Neurology·Karolien GoffinAsla Pitkänen
May 8, 2007·Acta Neuropathologica·Eleonora AronicaPeter Crino
May 25, 2007·Brain : a Journal of Neurology·Erik G PuffenbergerD Holmes Morton
Jul 7, 2007·Cancer Cell·David A Guertin, David M Sabatini
Apr 5, 2008·Annals of Neurology·Ling-Hui ZengMichael Wong
Feb 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jing ZhouLuis F Parada
Feb 21, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Philip A WilliamsF Edward Dudek
May 28, 2009·Disease Models & Mechanisms·M Cecilia LjungbergGabriella D'Arcangelo
May 29, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ling-Hui ZengMichael Wong
Jun 26, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Paul S BuckmasterXiling Wen
Dec 8, 2009·Trends in Neurosciences·Charles A Hoeffer, Eric Klann
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shilpa D KadamF Edward Dudek
Feb 12, 2010·Annals of the New York Academy of Sciences·Ksenia A Orlova, Peter B Crino
Apr 29, 2010·The Journal of Clinical Investigation·Ksenia A OrlovaPeter B Crino
Dec 8, 2010·Nature Reviews. Neurology·Annamaria VezzaniTallie Z Baram
Apr 30, 2011·Physiological Reviews·Helmut KettenmannAlexei Verkhratsky
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
May 25, 2012·Epilepsia·Alexander A SosunovGuy M McKhann
Jan 10, 2013·Trends in Neurosciences·Orrin DevinskyMichael A Rogawski
Jun 27, 2013·Annals of Neurology·Darcy A KruegerDavid Neal Franz
Mar 29, 2014·Frontiers in Molecular Neuroscience·Candi L Lasarge, Steve C Danzer

❮ Previous
Next ❯

Citations

Feb 10, 2016·Frontiers in Cellular Neuroscience·Jorge Landgrave-GómezRosalinda Guevara-Guzmán
Nov 6, 2015·Seizure : the Journal of the British Epilepsy Association·Xiao Ye-WeiXiong Xiao-Ming
Mar 21, 2016·Experimental Neurology·Michael S HesterSteve C Danzer
Apr 7, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rita CitraroGiovambattista De Sarro
Feb 4, 2016·Current Opinion in Neurology·Ingmar Blümcke, Harvey B Sarnat
Jun 25, 2016·Nature Reviews. Neurology·Peter B Crino
Apr 14, 2017·Expert Opinion on Therapeutic Targets·Kenneth A Myers, Ingrid E Scheffer
Feb 27, 2020·Epilepsy Currents·Laura A Jansen
Dec 25, 2019·Cold Spring Harbor Perspectives in Medicine·Amy E Clipperton-Allen, Damon T Page
Mar 7, 2020·Scientific Reports·Amber T LevineAnne E Anderson
May 19, 2018·International Journal of Molecular Sciences·Alice PolchiCarla Emiliani
Nov 19, 2020·Clinical EEG and Neuroscience·Luis A MartinezAnne E Anderson
Apr 21, 2021·Proceedings of the National Academy of Sciences of the United States of America·Vijendra SharmaArkady Khoutorsky
Sep 21, 2020·European Journal of Pharmacology·Dezaree Raut, Lokesh Kumar Bhatt
Oct 6, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Alissa M D'Gama, Annapurna Poduri
Oct 12, 2021·Brain Communications·Patrick B MoloneyNorman Delanty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.